Status:
COMPLETED
Genetic and Immunologic Basis of COVID-19 Infection
Lead Sponsor:
Mansoura University
Conditions:
Genetic Basis of COVID-19 Infection
Eligibility:
All Genders
1-50 years
Brief Summary
We will study genetic factors causing severe disease due to infection with SARS-COV-2 which may help to find targeted therapy
Eligibility Criteria
Inclusion
- severe COVID-19 infection
Exclusion
- Comorbidity ((DM, hypertension, Chronic liver or Kidney diseases, HIV, morbid obesity, Malignancy, Immunosuppressive therapy)
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04384250
Start Date
June 1 2020
End Date
December 30 2024
Last Update
March 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University
Al Mansurah, Dakahlyia, Egypt, 35516